In response to U.S. President Joseph Biden's Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” the U.S. Environmental Protection Agency (EPA), U.S. Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA) developed a plan to update, streamline and clarify their regulations and oversight mechanisms for products of biotechnology.
ISAAA Inc., in partnership with the Philippine Agriculture and Fisheries Biotechnology Program of the Department of Agriculture (DA Biotech) and the Committee of Food Security of the House of Representatives, held a virtual policy forum on Regulatory Path to Commercialization of Biotech Products on May 9, 2024, via Zoom.
Gene editing is an emerging modern biotechnology technique that significantly influences farming systems, resulting in high-yielding farm inputs. However, regulatory burdens create barriers to the development and adoption of such technologies. In a paper written by Graham Brookes and Stuart J. Smyth, a risk-appropriate and evidence-based regulatory environment is examined for facilitating the adoption of gene editing technology.
ISAAA Inc. and the Malaysian Biotechnology Information Centre (MABIC) are pleased to announce the 7th Asian Short Course on Agribiotechnology, Biosafety Regulation, and Communication (ASCA7). This intensive 5-day training program will be held at Maruay Garden Hotel, Bangkok, Thailand, on September 2-6, 2024.
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
Comments
Post a Comment